Literature DB >> 2040690

Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.

V K Chatterjee1, T Nagaya, L D Madison, S Datta, A Rentoumis, J L Jameson.   

Abstract

Thyroid hormone (T3) resistance is inherited in most cases in an autosomal dominant manner. The disorder is characterized by elevated free thyroid hormone levels and partial resistance to thyroid hormone at the cellular level. Distinct single amino acid substitutions in the ligand binding domain of the beta form of the thyroid hormone receptor have been described in two kindreds with this disorder. We used transient expression assays to characterize the functional properties of these receptor mutants, one containing a Gly to Arg change at amino acid 340 (G340R) and the other a Pro to His change at amino acid 448 (P448H). A nine amino acid carboxy terminal deletion (delta 448-456), analogous to an alteration that occurs in v-erbA, was also studied for comparison with the mutations that occur in the T3 resistance syndrome. None of the receptor mutants were able to mediate thyroid hormone dependent activation (TreTKCAT) or repression (TSH alpha CAT) of reporter genes when compared with the wild type receptor. In addition, the mutants inhibited the activity of normal alpha and beta receptor isoforms when examined in coexpression assays. This activity, referred to as dominant negative inhibition, was manifest with respect to both the positively and negatively regulated reporter genes. Although mutant receptor binding to DNA was unaffected, ligand binding studies showed that the G340R and delta 448-456 mutants failed to bind T3, whereas the P448H mutant bound hormone with reduced affinity (approximately 10% of normal) compared to the wild type receptor. Consistent with this finding, the P448H mutant receptor was partially active at higher T3 concentrations. Furthermore, the dominant negative inhibition elicited by the P448H receptor mutant at higher T3 concentrations was reversed in the presence of high doses of T3. These findings indicate that mutant beta receptors in patients with thyroid hormone resistance have reduced affinity for T3 and are functionally deficient, but impair the activity of normal receptors, thereby providing a mechanism for the dominant mode of inheritance in this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040690      PMCID: PMC296951          DOI: 10.1172/JCI115225

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Xenopus laevis alpha and beta thyroid hormone receptors.

Authors:  Y Yaoita; Y B Shi; D D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene.

Authors:  S J Usala; A E Bale; N Gesundheit; C Weinberger; R W Lash; F E Wondisford; O W McBride; B D Weintraub
Journal:  Mol Endocrinol       Date:  1988-12

3.  Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing.

Authors:  R J Koenig; M A Lazar; R A Hodin; G A Brent; P R Larsen; W W Chin; D D Moore
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

Review 4.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues.

Authors:  A Nakai; A Sakurai; G I Bell; L J DeGroot
Journal:  Mol Endocrinol       Date:  1988-11

Review 6.  Gene regulation. Action of leucine zippers.

Authors:  T Abel; T Maniatis
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

7.  Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist.

Authors:  K Damm; C C Thompson; R M Evans
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

8.  Expression of three forms of thyroid hormone receptor in human tissues.

Authors:  A Sakurai; A Nakai; L J DeGroot
Journal:  Mol Endocrinol       Date:  1989-02

9.  Identification of a thyroid hormone receptor that is pituitary-specific.

Authors:  R A Hodin; M A Lazar; B I Wintman; D S Darling; R J Koenig; P R Larsen; D D Moore; W W Chin
Journal:  Science       Date:  1989-04-07       Impact factor: 47.728

10.  Steroid hormone receptors compete for factors that mediate their enhancer function.

Authors:  M E Meyer; H Gronemeyer; B Turcotte; M T Bocquel; D Tasset; P Chambon
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

View more
  29 in total

1.  Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.

Authors:  R Parrilla; A J Mixson; J A McPherson; J H McClaskey; B D Weintraub
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.

Authors:  T N Collingwood; R Wagner; C H Matthews; R J Clifton-Bligh; M Gurnell; O Rajanayagam; M Agostini; R J Fletterick; P Beck-Peccoz; W Reinhardt; G Binder; M B Ranke; A Hermus; R D Hesch; J Lazarus; P Newrick; V Parfitt; P Raggatt; F de Zegher; V K Chatterjee
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

3.  Detection of a new de novo mutation at codon 251 of exon 8 of thyroid hormone receptor beta gene in an Italian kindred with resistance to thyroid hormone.

Authors:  E Macchia; M Agostini; G Sarkissian; G Giorgilli; D Canale; G Scartabelli; A Margotat; J Torresani; A Pinchera
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

4.  Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.

Authors:  X K Zhang; G Salbert; M O Lee; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.

Authors:  C A Meier; C Parkison; A Chen; K Ashizawa; S C Meier-Heusler; P Muchmore; S Y Cheng; B D Weintraub
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.

Authors:  A Baniahmad; S Y Tsai; B W O'Malley; M J Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor.

Authors:  K D Burman; Y Y Djuh; D Nicholson; P Rhooms; L Wartofsky; H G Fein; S J Usala; E H Hao; W E Bradley; J Berard
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

8.  Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

Authors:  Miguel López; Luis Varela; María J Vázquez; Sergio Rodríguez-Cuenca; Carmen R González; Vidya R Velagapudi; Donald A Morgan; Erik Schoenmakers; Khristofor Agassandian; Ricardo Lage; Pablo Blanco Martínez de Morentin; Sulay Tovar; Rubén Nogueiras; David Carling; Christopher Lelliott; Rosalía Gallego; Matej Oresic; Krishna Chatterjee; Asish K Saha; Kamal Rahmouni; Carlos Diéguez; Antonio Vidal-Puig
Journal:  Nat Med       Date:  2010-08-29       Impact factor: 53.440

9.  The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.

Authors:  M Au-Fliegner; E Helmer; J Casanova; B M Raaka; H H Samuels
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.

Authors:  R Wong; X G Zhu; M A Pineda; S Y Cheng; B D Weintraub
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.